AIRLINK 62.64 Increased By ▲ 2.21 (3.66%)
BOP 5.34 Decreased By ▼ -0.01 (-0.19%)
CNERGY 4.56 Decreased By ▼ -0.04 (-0.87%)
DFML 15.51 Increased By ▲ 0.67 (4.51%)
DGKC 66.31 Increased By ▲ 1.51 (2.33%)
FCCL 17.48 Increased By ▲ 0.62 (3.68%)
FFBL 27.97 Increased By ▲ 3.22 (13.01%)
FFL 9.25 Increased By ▲ 0.19 (2.1%)
GGL 10.07 Increased By ▲ 0.11 (1.1%)
HBL 105.30 Increased By ▲ 1.09 (1.05%)
HUBC 122.25 Increased By ▲ 4.73 (4.02%)
HUMNL 6.60 Increased By ▲ 0.06 (0.92%)
KEL 4.48 Decreased By ▼ -0.07 (-1.54%)
KOSM 4.45 Decreased By ▼ -0.12 (-2.63%)
MLCF 36.35 Increased By ▲ 0.94 (2.65%)
OGDC 122.95 Increased By ▲ 0.56 (0.46%)
PAEL 23.00 Increased By ▲ 1.09 (4.97%)
PIAA 29.34 Increased By ▲ 2.05 (7.51%)
PIBTL 5.85 Decreased By ▼ -0.09 (-1.52%)
PPL 107.40 Increased By ▲ 0.03 (0.03%)
PRL 27.07 Increased By ▲ 0.56 (2.11%)
PTC 18.18 Increased By ▲ 2.08 (12.92%)
SEARL 52.90 Decreased By ▼ -0.73 (-1.36%)
SNGP 63.21 Increased By ▲ 2.01 (3.28%)
SSGC 10.80 Increased By ▲ 0.05 (0.47%)
TELE 9.14 Increased By ▲ 0.65 (7.66%)
TPLP 11.44 Increased By ▲ 0.86 (8.13%)
TRG 71.10 Increased By ▲ 1.19 (1.7%)
UNITY 23.65 Increased By ▲ 0.14 (0.6%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)
BR100 6,945 Increased By 66.8 (0.97%)
BR30 22,817 Increased By 248.4 (1.1%)
KSE100 67,113 Increased By 565.1 (0.85%)
KSE30 22,082 Increased By 167.3 (0.76%)
World

Russia aims to boost Sputnik vaccine production abroad

  • Sputnik V has been approved in more than 15 countries, including several ex-Soviet republics but also Argentina, Tunisia and Pakistan.
Published February 3, 2021

MOSCOW: Russia is working to increase production of its Sputnik V coronavirus vaccine in foreign countries, the Kremlin said Wednesday, as many European nations struggle to roll out their jabs.

"In the very near future there are plans to establish production in foreign countries, which will satisfy the demand from more and more countries," Kremlin spokesman Dmitry Peskov told reporters.

The comments come a day after The Lancet medical journal published results showing Sputnik V -- named after the Soviet-era satellite -- to be safe and 91.6 percent effective, allaying concerns over transparency.

Russia registered the vaccine in August months ahead of Western competitors but before large-scale clinical trials, leaving many experts wary.

Its developers later said the vaccine is over 90 percent effective and Russia began inoculating its citizens with the jab in December.

Sputnik V has been approved in more than 15 countries, including several ex-Soviet republics but also Argentina, Tunisia and Pakistan.

The Russian Direct Investment Fund (RDIF), which helped finance Sputnik V, has said that more than 2 million people have been inoculated with the jab around the world.

RDIF applied for registration of Sputnik V in the European Union last month and German Chancellor Angela Merkel has expressed openness to its use once the jab receives the regulatory nod.

Comments

Comments are closed.